Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Drug localisation and growth inhibition studies of vindesine-monoclonal anti-CEA conjugates in a human tumour xenograftG F Rowland, R G Simmonds, V A Gore, et al.
Plant Physiology|August 1, 1989
Phosphate Starvation Inducible ;Bypasses' of Adenylate and Phosphate Dependent Glycolytic Enzymes in Brassica nigra Suspension CellsS M Duff, G B Moorhead, D D Lefebvre, et al.
The Journal of Biological Chemistry|October 25, 1992
Phosphate starvation-inducible synthesis of the alpha-subunit of the pyrophosphate-dependent phosphofructokinase in black mustard suspension cellsM E Theodorou, F A Cornel, S M Duff, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 26, 1998
Altering hemoglobin levels changes energy status in maize cells under hypoxiaA W Sowa, S M Duff, P A Guy, et al.
Clinical and Experimental Immunology|January 1, 1981
The relationship between hyperglycaemia and renal immune complex deposition in mice with inherited diabetesC J Meade, D R Brandon, W Smith, et al.
Archives of Physical Medicine and Rehabilitation|May 11, 2001
Upper-limb function in Australian children with traumatic brain injury: A controlled, prospective studyM A Wallen, S Mackay, S M Duff, et al.
British Journal of Cancer|January 1, 1983
Selective cytotoxicity against human tumour cells by a vindesine-monoclonal antibody conjugateM J Embleton, G F Rowland, R G Simmonds, et al.
Plant Physiology|June 1, 1990
Response to Phosphate Deprivation in Brassica nigra Suspension Cells : Enhancement of Intracellular, Cell Surface, and Secreted Phosphatase Activities Compared to Increases in Pi-Absorption RateD D Lefebvre, S M Duff, C A Fife, et al.
Behring Institute Mitteilungen|May 1, 1984
Experience in the preparation and experimental use of immunocytostaticsM J Embleton, M V Pimm, M C Garnett, et al.
British Journal of Cancer|January 1, 1983
Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancerC H Ford, C E Newman, J R Johnson, et al.
Pageof 5